E7080 Food Effect Study in Healthy Subjects

Trial Profile

E7080 Food Effect Study in Healthy Subjects

Phase of Trial: Phase I

Latest Information Update: 12 Mar 2015

At a glance

  • Drugs Lenvatinib (Primary)
  • Indications Endometrial cancer; Liver cancer; Lymphoma; Malignant melanoma; Non-small cell lung cancer; Ovarian cancer; Renal cancer; Thyroid cancer
  • Focus Pharmacokinetics
  • Sponsors Eisai Inc
  • Most Recent Events

    • 19 Feb 2014 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
    • 01 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Apr 2011 Planned end date changed from Jan 2011 to Nov 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top